Channavix Therapeutics and Peregrine BioVentures are developing two patent families related to long-lasting, non-opioid, non-addictive pain therapeutics.
Jones will accept his award at the 72nd annual UB School of Management Alumni Association Awards Ceremony, where several alumni will also be honored for their career and impact.
Now in its fifth year, the Social Impact Fellows program brings together students from three UB schools to create social innovation in Western New York.